WireSift
Subscribe
← AI Adoption Tracker
WireSift Research · AI Adoption Tracker · Q1 2026

PODDInsulet Corporation

AI adoption · Q1 2026 earnings call

Health CareSilent
AI mentions
0
extracted from this call
Max specificity
—
—
AI revenue
Not disclosed
no breakout in this call
Insulet's Q1 2026 earnings call contained no explicit mentions of artificial intelligence, machine learning, generative AI, or related technologies. The company's innovation discussion centered on closed-loop algorithm improvements, sensor integrations, and automated insulin delivery (AID) systems, but these were framed in terms of medical device algorithms and clinical outcomes rather than AI/ML. No AI products, partnerships, infrastructure investments, or internal AI productivity initiatives were disclosed.
Public Company AI Adoption Index
See full leaderboard →
Composite
0/ 100
#296 non-tech · #365 overall · #43 in Health Care
Depth · 40%
0
stage: silent · max spec: —
Disclosure · 40%
0
no quantified disclosure
Breadth · 20%
0
no adoption scopes
The silence is the data

Insulet Corporationdidn’t mention AI once on its Q1 2026 earnings call.

Across the S&P 500 companies reporting Q1 2026 so far, 23% are silent on AI on their earnings call — meaning AI didn’t come up in prepared remarks or Q&A. Insulet Corporation is one of them.

Silence isn’t neutral. Earnings calls are where management chooses what to put on the record. When a topic is dominating headlines and yet doesn’t surface here, that’s a signal: either AI isn’t material to the business yet, or management isn’t ready to position the company against the narrative. Both are interesting.

We’ll watch the next call. As soon as AI is mentioned — even once — this page updates with the verbatim quote, the speaker, and the section it appeared in.

Where this fits

The full distribution by sector and stage — including which sectors concentrate the silent cohort — lives on the main tracker.

See the full chart →
Related

Compare with peers.

Other companies in the same sector and at the same AI adoption stage.

Stay informed

Independent research, direct to your inbox.

Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.

By subscribing, you agree to our Privacy Policy.

Sourced from primary documents · See the methodology for the extraction approach.